<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Smith, Alvin W</style></author><author><style face="normal" font="default" size="100%">Iversen, Patrick L</style></author><author><style face="normal" font="default" size="100%">O'Hanley, Peter D</style></author><author><style face="normal" font="default" size="100%">Skilling, Douglas E</style></author><author><style face="normal" font="default" size="100%">Christensen, Janet R</style></author><author><style face="normal" font="default" size="100%">Weaver, Sherry S</style></author><author><style face="normal" font="default" size="100%">Longley, Kimberli</style></author><author><style face="normal" font="default" size="100%">Stone, Michael A</style></author><author><style face="normal" font="default" size="100%">Poet, Steve E</style></author><author><style face="normal" font="default" size="100%">Matson, David O</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Virus-specific antiviral treatment for controlling severe and fatal outbreaks of feline calicivirus infection.</style></title><secondary-title><style face="normal" font="default" size="100%">American journal of veterinary research</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Am. J. Vet. Res.</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Animals</style></keyword><keyword><style  face="normal" font="default" size="100%">Antiviral Agents</style></keyword><keyword><style  face="normal" font="default" size="100%">Caliciviridae Infections</style></keyword><keyword><style  face="normal" font="default" size="100%">Calicivirus, Feline</style></keyword><keyword><style  face="normal" font="default" size="100%">Cat Diseases</style></keyword><keyword><style  face="normal" font="default" size="100%">Cats</style></keyword><keyword><style  face="normal" font="default" size="100%">Disease Outbreaks</style></keyword><keyword><style  face="normal" font="default" size="100%">Female</style></keyword><keyword><style  face="normal" font="default" size="100%">Male</style></keyword><keyword><style  face="normal" font="default" size="100%">Morpholines</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008 Jan</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">69</style></volume><pages><style face="normal" font="default" size="100%">23-32</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">To test the life-sparing and therapeutic effect of a parenterally administered virus-specific antiviral phosphorodiamidate morpholino oligomer (PMO) for treating kittens during outbreaks of severe viral disease.</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/18167083?dopt=Abstract</style></custom1></record></records></xml>